Chemoresistance, whether intrinsic or acquired, is a major obstacle in the treatment of
cancer. The resistance of cancer cells to chemotherapeutic drugs can result from various …

Enzalutamide (Enz) is a next-generation androgen receptor (AR) antagonist used to treat
castration-resistant prostate cancer (CRPC). Unfortunately, the relapsing nature of CRPC …

Long non‐coding RNAs (lncRNAs) have come out as critical molecular regulators of human
tumorigenesis. In this study, we sought to identify and functionally characterize lncRNAs as …

Long non-coding RNAs (lncRNAs) act as crucial modulators during the development of
diverse cancers. Although various types of lncRNAs in prostate cancer (PCa) have been …

The contributions of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) to breast
cancer are critical areas of investigation. In this study, we identified a novel lncRNA RP11 …

Hepatocellular carcinoma (HCC) is considered the second most deadly cancer worldwide.
Due to the absence of early diagnostic markers and effective therapeutic approaches …

Accumulating evidence indicates that long noncoding RNAs (lncRNAs) are abnormal
expression in various malignant tumors. Our previous research demonstrated that focally …

Prostate cancer (PCa) is a common malignant tumor with increasing incidence and high
heterogeneity among males worldwide. In the era of big data and artificial intelligence, the …

Background Ovarian cancer has one of the highest mortality rates among all gynaecological
malignancies, and increasing evidence suggests that lncRNAs are widely involved in the …

Background: Epithelial ovarian cancer (EOC) is a disease with high morbidity and mortality
worldwide, which is seriously harmful to female health. LncRNA has an important …